From the Department of Translational and Precision Medicine (S.N., O.R., S. Gioia, M.P., L.R., F.A.), Department of Radiological Sciences, Oncology, and Anatomical Pathology (M.D.M.), and Department of Public Health and Infectious Diseases (A.S., A.D.R.), Sapienza University of Rome, Viale dell'Università 37, 00161 Rome, Italy; Departments of Gastroenterology (L.T., M.B., S. Gitto, F.S.) and Radiology (G.M., C.C.), University of Modena and Reggio Emilia, Modena, Italy; Department of Interventional Radiology, Santa Maria Goretti Hospital, Latina, Italy (G.P.); and Department of Experimental and Clinical Medicine, University of Florence, Florence, Italy (S. Gitto).
Radiology. 2021 Apr;299(1):133-140. doi: 10.1148/radiol.2021203051. Epub 2021 Feb 2.
Background Cirrhosis leads to portal hypertension and to the consequent formation of spontaneous portosystemic shunts (SPSSs), leading to complications related to the diversion of portal blood into the systemic circulation, which is called portosystemic shunt syndrome. Purpose To investigate the characteristics of patients with cirrhosis and an SPSS and secondarily to assess the prognostic impact of SPSSs on portal hypertension-related complications and transplant-free survival. Materials and Methods A retrospective database review of patients with cirrhosis (observed from March 2015 to July 2019) was performed to identify patients with CT imaging and outcomes data. For each patient, clinical and biochemical data were collected, and the presence, types, and sizes of SPSSs were investigated with CT. Patients were followed for a mean of 27.5 months ± 22.8. Multivariable logistic analysis was used to identify the clinical characteristics associated with the presence of SPSSs (any size) and presence of SPSSs 1 cm or larger. Competitive risk analysis (Fine and Gray model) was used to identify the association between SPSSs and complications and mortality. Results Two hundred twenty-two patients with cirrhosis (157 male, 65 female; mean age, 62 years ± 12 [standard deviation]) were evaluated. An SPSS was found in 141 of 222 patients (63.5%), and 40 of 222 (18%) had a shunt diameter of at least 1 cm. At presentation, variables independently associated with the presence of SPSSs (any size) were portal vein thrombosis (odds ratio, 5.5; = .008) and Child-Pugh class C (odds ratio, 3.0; = .03). Previous hepatic encephalopathy (odds ratio, 4.4; = .001) and portal vein thrombosis (odds ratio, 5.3; = .001) were the only variables associated with SPSSs larger than 1 cm. Patients with SPSSs of any size had higher mortality (subdistribution hazard ratio, 1.9; < .001) and higher frequency of hepatic encephalopathy (subdistribution hazard ratio, 2.3; = .023), gastrointestinal bleeding (subdistribution hazard ratio, 2.9; = .039), and portal vein thrombosis (subdistribution hazard ratio, 7.6; = .005). Conclusion The presence of spontaneous portosystemic shunts on CT images in patients with cirrhosis was associated with higher mortality and complications, including portal vein thrombosis, hepatic encephalopathy, and gastrointestinal bleeding. © RSNA, 2021 See also the editorial by Reeder in this issue.
肝硬化导致门静脉高压,继而形成自发性门体分流(SPSS),导致与门静脉血液分流至体循环相关的并发症,这种分流称为门体分流综合征。目的:探讨肝硬化伴 SPSS 患者的特征,其次评估 SPSS 对门静脉高压相关并发症和无移植生存的预后影响。材料与方法:对 2015 年 3 月至 2019 年 7 月期间接受 CT 成像和结局数据的肝硬化患者进行回顾性数据库分析。对每位患者收集临床和生化数据,并使用 CT 调查 SPSS 的存在、类型和大小。患者平均随访 27.5 个月±22.8 个月。多变量逻辑分析用于确定与 SPSS 存在(任何大小)和 1cm 或更大的 SPSS 存在相关的临床特征。竞争风险分析(Fine 和 Gray 模型)用于确定 SPSS 与并发症和死亡率之间的关联。结果:共评估了 222 例肝硬化患者(157 例男性,65 例女性;平均年龄 62 岁±12[标准差])。在 222 例患者中,141 例(63.5%)发现有 SPSS,40 例(18%)的分流直径至少为 1cm。在初诊时,与存在 SPSS(任何大小)独立相关的变量为门静脉血栓形成(比值比,5.5; =.008)和 Child-Pugh 分级 C(比值比,3.0; =.03)。既往肝性脑病(比值比,4.4; =.001)和门静脉血栓形成(比值比,5.3; =.001)是唯一与直径大于 1cm 的 SPSS 相关的变量。任何大小的 SPSS 患者的死亡率更高(亚分布危险比,1.9; <.001),肝性脑病(亚分布危险比,2.3; =.023)、胃肠道出血(亚分布危险比,2.9; =.039)和门静脉血栓形成(亚分布危险比,7.6; =.005)的发生率更高。结论:肝硬化患者 CT 图像上存在自发性门体分流与更高的死亡率和并发症相关,包括门静脉血栓形成、肝性脑病和胃肠道出血。